CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND NONCONTROLLING INTEREST - USD ($) $ in Thousands	Total	Common Stock Class A	Common Stock Class V	Common Stock Common Stock Class A	Common Stock Common Stock Class V	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total Stockholders' Equity Attributable to indie Semiconductor, Inc.	Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2023				163,193,278	18,694,332
Beginning balance at Dec. 31, 2023	$ 477,025			$ 16	$ 2	$ 813,742	$ (361,441)	$ (6,170)	$ 446,149	$ 30,876
Vesting of equity awards (in shares)				26,931
Issuance per net settlement of equity awards and cash exercise of stock options (in shares)				2,166,146
Issuance per net settlement of equity awards and cash exercise of stock options	677					473			473	204
Issuance per Exchange of Class V to Class A (in shares)				100,000	(100,000)
Issuance per Exchange of ADK LLC units to Class A (in shares)				30,516
Share-based compensation, including amounts associated with the EEPP	18,608					18,608			18,608
Issuance per settlement of contingent considerations (in shares)				62,562
Issuance per settlement of contingent considerations	548					500			500	48
Shares issued for Investment in Expedera (in shares)				525,000
Shares issued for Investment in Expedera	3,385			$ 1		2,963			2,964	421
Net loss	(34,223)						(31,179)		(31,179)	(3,044)
Foreign currency translation adjustment	(4,549)							(4,638)	(4,638)	89
Ending balance (in shares) at Mar. 31, 2024				166,104,433	18,594,332
Ending balance at Mar. 31, 2024	461,471			$ 17	$ 2	836,286	(392,620)	(10,808)	432,877	28,594
Beginning balance (in shares) at Dec. 31, 2023				163,193,278	18,694,332
Beginning balance at Dec. 31, 2023	477,025			$ 16	$ 2	813,742	(361,441)	(6,170)	446,149	30,876
Net loss	(55,223)
Ending balance (in shares) at Jun. 30, 2024				176,542,919	18,044,332
Ending balance at Jun. 30, 2024	502,633			$ 18	$ 2	896,220	(411,780)	(13,750)	470,710	31,923
Beginning balance (in shares) at Mar. 31, 2024				166,104,433	18,594,332
Beginning balance at Mar. 31, 2024	461,471			$ 17	$ 2	836,286	(392,620)	(10,808)	432,877	28,594
Vesting of equity awards (in shares)				26,064
Issuance per net settlement of equity awards and cash exercise of stock options (in shares)				2,317,279
Issuance per net settlement of equity awards and cash exercise of stock options	3,118					2,916			2,916	202
Issuance per Exchange of Class V to Class A (in shares)				550,000	(550,000)
Share-based compensation, including amounts associated with the EEPP	13,293					13,293			13,293
Issuance in connection with At-The-Market equity offering (in shares)				345,052
Issuance in connection with At-The-Market equity offering	2,318					2,157			2,157	161
Issuance per settlement of contingent considerations (in shares)				7,200,091
Issuance per settlement of contingent considerations	46,664			$ 1		41,568			41,569	5,095
Net loss	(21,000)						(19,160)		(19,160)	(1,840)
Foreign currency translation adjustment	(3,231)							(2,942)	(2,942)	(289)
Ending balance (in shares) at Jun. 30, 2024				176,542,919	18,044,332
Ending balance at Jun. 30, 2024	502,633			$ 18	$ 2	896,220	(411,780)	(13,750)	470,710	31,923
Beginning balance (in shares) at Dec. 31, 2024		189,163,408	17,671,251	189,163,408	17,671,251
Beginning balance at Dec. 31, 2024	445,395			$ 19	$ 2	936,564	(494,044)	(24,655)	417,886	27,509
Issuance per net settlement of equity awards and cash exercise of stock options (in shares)				3,446,663
Issuance per net settlement of equity awards and cash exercise of stock options	472					78			78	394
Issuance per Exchange of Class V to Class A (in shares)				50,000	(50,000)
Issuance per Exchange of ADK LLC units to Class A (in shares)				44,863
Share-based compensation, including amounts associated with the EEPP	16,561					16,561			16,561
Issuance per settlement of contingent considerations (in shares)				1,680,579
Issuance per settlement of contingent considerations	4,130					3,685			3,685	445
Net loss	(37,171)						(34,546)		(34,546)	(2,625)
Foreign currency translation adjustment	2,346							1,904	1,904	442
Ending balance (in shares) at Mar. 31, 2025				194,385,513	17,621,251
Ending balance at Mar. 31, 2025	431,733			$ 19	$ 2	956,888	(528,590)	(22,751)	405,568	26,165
Beginning balance (in shares) at Dec. 31, 2024		189,163,408	17,671,251	189,163,408	17,671,251
Beginning balance at Dec. 31, 2024	445,395			$ 19	$ 2	936,564	(494,044)	(24,655)	417,886	27,509
Net loss	(78,789)
Ending balance (in shares) at Jun. 30, 2025		196,642,842	17,621,251	196,642,842	17,621,251
Ending balance at Jun. 30, 2025	415,096			$ 20	$ 2	963,886	(567,628)	(5,873)	390,407	24,689
Beginning balance (in shares) at Mar. 31, 2025				194,385,513	17,621,251
Beginning balance at Mar. 31, 2025	431,733			$ 19	$ 2	956,888	(528,590)	(22,751)	405,568	26,165
Issuance per net settlement of equity awards and cash exercise of stock options (in shares)				2,227,729
Issuance per net settlement of equity awards and cash exercise of stock options	44			$ 1		(167)			(166)	210
Issuance on earn out awards (in shares)				29,600
Share-based compensation, including amounts associated with the EEPP	7,165					7,165			7,165
Net loss	(41,618)						(39,038)		(39,038)	(2,580)
Foreign currency translation adjustment	17,772							16,878	16,878	894
Ending balance (in shares) at Jun. 30, 2025		196,642,842	17,621,251	196,642,842	17,621,251
Ending balance at Jun. 30, 2025	$ 415,096			$ 20	$ 2	$ 963,886	$ (567,628)	$ (5,873)	$ 390,407	$ 24,689